Switch to local therapy with metronidazole plus meglumine in a case of otic leishmaniasis due to hepatic toxicity of intramuscular meglumine

Travel Med Infect Dis. 2023 Jan-Feb:51:102513. doi: 10.1016/j.tmaid.2022.102513. Epub 2022 Nov 24.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antiprotozoal Agents* / adverse effects
  • Drug-Related Side Effects and Adverse Reactions*
  • Humans
  • Leishmaniasis, Cutaneous* / drug therapy
  • Meglumine / adverse effects
  • Metronidazole / therapeutic use
  • Organometallic Compounds* / therapeutic use

Substances

  • Meglumine
  • Metronidazole
  • Antiprotozoal Agents
  • Organometallic Compounds